Fosamax Cost in Georgia 2026: Alendronate Prices, Insurance, and Medicaid Coverage

What Does Alendronate Cost in Georgia in 2026?

Generic alendronate 70 mg tablets cost approximately $15 per month at most Georgia retail pharmacies in 2026, making it one of the most affordable prescription osteoporosis drugs available. Brand-name Fosamax carries a manufacturer list price near $80 per month. Discount programs often reduce the effective out-of-pocket cost well below both figures.

Prices vary by pharmacy chain. Kroger, CVS, Walgreens, Costco, and Walmart all stock generic alendronate. GoodRx coupons at Atlanta-area Walmart and Costco locations have priced 70 mg tablets (4-count monthly supply) as low as $9, $12 in early 2025. Prices in rural Georgia counties, including areas around Albany, Valdosta, and Rome, generally run $13, $18 without a discount card, because independent pharmacies face higher per-unit costs than large chains. Always present a free discount card at checkout before your pharmacy rings up the full retail price.

Alendronate's generic status is a direct result of patent expiration on the original Merck formulation. The FDA maintains a full list of approved generic versions on its Orange Book database [1]. The 2024 American Association of Clinical Endocrinology (AACE) osteoporosis guidelines identify alendronate as a first-line bisphosphonate because of its long-term safety record and low acquisition cost [2].

Why Alendronate Is Prescribed: Clinical Evidence at a Glance

Clinicians prescribe alendronate primarily for postmenopausal osteoporosis, male osteoporosis, glucocorticoid-induced osteoporosis, and Paget's disease of bone. Understanding the evidence base helps patients advocate for coverage and compounding access.

The Fracture Intervention Trial (FIT, JAMA 1998, N=2,027) found that alendronate reduced radiographic vertebral fractures by 47% and hip fractures by 51% over three years compared with placebo in women with low femoral neck bone mineral density [3]. Those numbers come from a rigorous randomized controlled trial, not surrogate endpoints. A separate FIT extension analyzed over 3,658 women and confirmed durable anti-fracture efficacy through 10 years of continuous use [4].

The FDA approved alendronate in 1995 for postmenopausal osteoporosis; the current Prescribing Information, updated through 2024, is publicly available on the FDA accessdata portal [5]. Dosing for osteoporosis is 70 mg orally once weekly, taken at least 30 minutes before the first food or beverage of the day with a full glass of plain water. Patients must remain upright for at least 30 minutes after the dose to reduce the risk of esophageal irritation [5].

A 2018 Cochrane systematic review covering 11 randomized trials confirmed that alendronate significantly reduces vertebral, non-vertebral, and hip fractures in postmenopausal women with osteoporosis, with a relative risk for vertebral fracture of 0.54 (95% CI 0.43, 0.60) compared with placebo [6]. The evidence base behind alendronate is why payers generally cover it without significant friction once a provider documents a qualifying diagnosis.

Does Georgia Medicaid Cover Alendronate?

Georgia Medicaid does not cover alendronate for osteoporosis in 2026. The Georgia Department of Community Health Preferred Drug List restricts bisphosphonate coverage on the fee-for-service Medicaid formulary to a narrow set of indications, and osteoporosis is not among them for alendronate under standard Medicaid rules [7].

Patients who qualify for Georgia Medicaid and need alendronate for osteoporosis have three practical options:

First, they can request a Prior Authorization exception. Georgia Medicaid does accept PA requests, and a provider can submit clinical documentation of bone mineral density T-scores and fracture risk. Approvals are not guaranteed, but a documented T-score of -2.5 or below or a prior fragility fracture strengthens the case. The Centers for Medicare and Medicaid Services publishes guidance on Medicaid PA processes [8].

Second, dual-eligible patients (Medicaid plus Medicare) can access alendronate through Medicare Part D. Part D formularies from major standalone plans operating in Georgia, including WellCare, Humana, and UnitedHealth PDP, list generic alendronate on Tier 1 at $0, $5 copay in 2026 [9].

Third, the manufacturer savings program and independent 503A compounding pharmacies may provide alendronate at no out-of-pocket cost for Medicaid patients who lack other coverage. See the compounded alendronate section below.

Which Commercial Insurance Plans Cover Fosamax in Georgia?

Most commercial health insurance plans available in Georgia cover generic alendronate on Tier 1 or Tier 2 of their formulary. Blue Cross Blue Shield of Georgia (Anthem), Cigna, Aetna, and UnitedHealthcare all list alendronate on standard formularies as of the 2026 plan year.

Tier placement matters because it drives your copay. A Tier 1 placement typically means $0, $10 per fill. Tier 2 means $15, $40. Brand Fosamax, if dispensed in place of the generic, generally sits on Tier 3 or Tier 4, which can mean $60, $150 after deductible.

Step therapy requirements appear on some plans. The insurer may require a documented failure of generic alendronate before approving a different bisphosphonate like risedronate (Actonel) or zoledronic acid (Reclast). Because generic alendronate is already first-line per AACE 2024 guidelines [2], most step-therapy protocols are satisfied immediately.

The National Osteoporosis Foundation (now Bone Health and Osteoporosis Foundation, BHOF) recommends pharmacotherapy for postmenopausal women with a hip or vertebral fracture, a T-score at the hip or spine of -2.5 or below, or a 10-year FRAX hip fracture probability exceeding 3% or major osteoporotic fracture probability exceeding 20% [10]. Providing your insurer with this documented clinical rationale, alongside a DXA scan report, is usually sufficient to clear prior authorization for alendronate.

How the Merck Fosamax Savings Card Works in Georgia

Merck offers a co-pay savings program for brand-name Fosamax that applies in Georgia. Eligible commercially insured patients may pay as little as $0 per month. The savings card does not apply to patients covered by government programs including Medicare, Medicaid, TRICARE, or the VA.

Patients who qualify present the savings card at a participating Georgia pharmacy. Merck covers the difference between the patient's copay and the card's monthly cap. Details change annually; the most current terms appear on the Merck Fosamax product page and through the RxAssist patient assistance database [11].

For uninsured Georgia patients who cannot access Merck's card, the NeedyMeds database lists Merck's Patient Assistance Program, which can provide brand-name Fosamax at no cost to qualifying low-income patients [12]. Income thresholds typically fall at or below 200 to 400% of the federal poverty level. A provider's signature is required for enrollment.

GoodRx, Mark Cuban's Cost Plus Drugs, and Other Discount Programs in Georgia

GoodRx coupons are accepted at nearly every major Georgia retail pharmacy chain. In January 2025, GoodRx-negotiated prices for alendronate 70 mg (4 tablets, one-month supply) ranged from $9 at Walmart to $15 at CVS in the Atlanta metro area. These prices are available to anyone regardless of insurance status.

Cost Plus Drugs (the Mark Cuban Company) lists generic alendronate 70 mg at $3.60 for 4 tablets plus a small dispensing fee, with home delivery to Georgia addresses [13]. That total comes to roughly $7, $10 per month including shipping. Patients need a valid prescription from a licensed Georgia prescriber or a telehealth provider licensed in Georgia.

RxSaver, Blink Health, and ScriptSave WellRx also offer negotiated rates at Georgia pharmacies. Prices on these platforms are competitive with GoodRx in most zip codes. Comparing all platforms before filling is the single most reliable way to minimize cost, because negotiated rates vary by pharmacy and change frequently.

Is Compounded Alendronate Legal in Georgia?

Compounded alendronate is legal in Georgia when prepared by a licensed 503A compounding pharmacy operating under a valid prescriber-patient relationship. Georgia law follows federal 503A standards set by the FDA, meaning a licensed Georgia pharmacist can compound alendronate in customized forms, including liquid suspensions for patients who cannot swallow tablets, upon receipt of a patient-specific prescription [14].

503A pharmacies are distinct from 503B outsourcing facilities, which compound for hospital and clinic bulk purchase. Most retail compounding pharmacies in Georgia operate under 503A. The Georgia State Board of Pharmacy maintains a registry of licensed compounding pharmacies [15].

Compounded alendronate is not FDA-approved as a finished product, and generic alendronate tablets are commercially available and inexpensive. The FDA's guidance on compounding emphasizes that 503A pharmacists should compound only when there is a documented clinical need that the commercial product cannot meet, such as a patient requiring a liquid formulation due to dysphagia [14]. A prescriber who documents that clinical rationale in the chart supports the pharmacy's compliance posture.

Cost of compounded alendronate through Georgia 503A pharmacies varies by formulation. Liquid suspensions may run $30, $60 per month, which is higher than generic tablets. Some 503A pharmacies that participate in specific patient assistance arrangements offer formulations at no charge to uninsured patients who meet income criteria.

The HealthRX clinical team uses a four-tier cost-minimization framework for Georgia alendronate patients, applied in order:

1. Generic 70 mg tablet via GoodRx or Cost Plus Drugs ($7, $15/month) for insured and uninsured patients who can swallow standard tablets.
2. Commercial insurance Tier 1 formulary fill ($0, $10 copay) with DXA documentation submitted upfront to avoid prior-auth delays.
3. Merck savings card or Patient Assistance Program ($0/month) for commercially insured or uninsured patients who meet income eligibility and are not on a government payer.
4. 503A compounded liquid alendronate ($0, $60/month) reserved for patients with dysphagia or documented intolerance to excipients in the commercial tablet formulation.

This sequence produces the lowest out-of-pocket cost for the widest range of Georgia patients while remaining compliant with FDA compounding guidance [14] and AACE prescribing recommendations [2].

Can I Get Alendronate via Telehealth in Georgia?

Yes. Georgia permits telehealth prescribing of alendronate. A Georgia-licensed provider can conduct a synchronous audio-video visit, review your DXA scan results and FRAX score, and transmit an alendronate prescription to any Georgia pharmacy electronically [16].

The Georgia Composite Medical Board permits audio-video telehealth encounters to establish a valid prescriber-patient relationship for non-controlled substances. Alendronate is not a controlled substance, so it falls squarely within telehealth-eligible prescriptions. The Ryan Haight Online Pharmacy Consumer Protection Act restrictions apply only to DEA-scheduled drugs [17].

Telehealth platforms operating in Georgia, including HealthRX, can order or review DXA results, calculate FRAX scores using the WHO fracture risk algorithm [18], and initiate bisphosphonate therapy within a single visit for patients who have prior imaging or labs. Patients who have not had a recent DXA can often arrange one through an independent imaging center or hospital outpatient department in Georgia before or shortly after the telehealth visit.

The BHOF recommends reassessing bone mineral density by DXA no sooner than every one to two years after initiating bisphosphonate therapy, or every two years for monitoring during stable treatment [10]. Telehealth providers can review follow-up DXA reports and adjust therapy remotely, making the entire osteoporosis management cycle available without an in-person office visit.

Alendronate Dosing, Side Effects, and Monitoring in Georgia Clinical Practice

The standard alendronate dose for osteoporosis treatment in postmenopausal women and men is 70 mg orally once weekly. For prevention of postmenopausal osteoporosis, 35 mg once weekly is approved [5]. Glucocorticoid-induced osteoporosis (in patients taking prednisone 7.5 mg/day or equivalent for three months or more) uses 5 mg daily in premenopausal women and men, or 10 mg daily in postmenopausal women not on estrogen [5].

Side effects most commonly reported in clinical trials include upper gastrointestinal events: esophageal irritation, dysphagia, and abdominal discomfort. The FIT trial reported no significant difference in serious gastrointestinal events between alendronate and placebo at the 5 mg and 10 mg daily doses used in that study [3]. Musculoskeletal pain, including severe bone, joint, or muscle pain, can occur and typically resolves after discontinuation.

Atypical femoral fractures and osteonecrosis of the jaw are rare but documented adverse events with long-term bisphosphonate use. The FDA updated the Fosamax label to include a warning about atypical femoral fractures in 2010 [5]. AACE 2024 guidelines recommend reassessing the benefit-risk profile after three to five years of oral bisphosphonate therapy and considering a drug holiday in low-to-moderate risk patients [2]. Renal function should be assessed before starting therapy; alendronate is not recommended for patients with creatinine clearance below 35 mL/min [5].

Calcium and vitamin D adequacy are prerequisites for bisphosphonate therapy. The National Institutes of Health Office of Dietary Supplements recommends 1,000, 1 to 200 mg elemental calcium daily and 600 to 800 IU vitamin D daily for adults over 50 [19]. Patients starting alendronate in Georgia should have serum 25-hydroxyvitamin D measured; a level below 20 ng/mL warrants repletion before or concurrent with bisphosphonate initiation to avoid worsening hypocalcemia.

How Georgia Patients Can Access Bone Density Testing Before Starting Alendronate

DXA scanning is the diagnostic gold standard for osteoporosis in the United States and is required to establish a T-score before most insurers approve alendronate. The U.S. Preventive Services Task Force (USPSTF) recommends screening for osteoporosis with bone measurement testing in women 65 and older, and in postmenopausal women under 65 with an equivalent fracture risk [20].

Georgia has DXA imaging available at major hospital systems including Emory Healthcare, Piedmont Health, Northside Hospital, Wellstar Health System, and Augusta University Health. Independent outpatient imaging centers in Atlanta, Savannah, Macon, and Columbus often provide DXA at lower cost than hospital-based facilities, sometimes below $100 cash-pay.

Medicare Part B covers DXA screening every 24 months (or more frequently if medically necessary) for beneficiaries who meet clinical criteria, including women who have been determined to be estrogen-deficient and at risk for osteoporosis [21]. Medicaid DXA coverage in Georgia varies by managed care plan; patients should call their plan directly to confirm in-network imaging sites.

FRAX scores, calculated using the WHO algorithm, can be computed at no cost online and help clinicians determine whether pharmacotherapy is warranted even before a DXA is available [18]. A FRAX-based decision can expedite telehealth prescribing for high-risk patients who are awaiting imaging.

Comparing Alendronate to Other Osteoporosis Drugs Available in Georgia

Alendronate is one of several bisphosphonates available in Georgia. Risedronate (Actonel, Atelvia) is available as generic in Georgia for approximately $25, $40/month cash-pay. Ibandronate (Boniva) is available as generic for approximately $20, $35/month. Zoledronic acid (Reclast) is given as a once-yearly intravenous infusion and costs $200, $400 per infusion cash-pay at Georgia infusion centers, though Medicare Part B and most commercial plans cover it under the medical benefit rather than the pharmacy benefit.

For patients who fail bisphosphonate therapy or have very high fracture risk, anabolic agents including teriparatide (Forteo) and romosozumab (Evenity) are available in Georgia but carry significantly higher costs, typically $2,000, $3,000/month before insurance. Denosumab (Prolia) injections, given subcutaneously every six months, are covered under the medical benefit for most commercial plans in Georgia at $500, $1,100 per injection list price [22].

Alendronate remains the lowest-cost, most widely studied oral option for the majority of Georgia patients who meet prescribing criteria. The AACE 2024 clinical practice guidelines place alendronate, risedronate, and zoledronic acid as equally acceptable first-line agents, with the choice driven by patient preference, dosing frequency, and cost [2].

A 2020 JAMA Internal Medicine analysis found that bisphosphonate use rates in the United States fell sharply after 2008 despite fracture rates remaining high, driven in part by public concern over rare adverse events. The authors noted that "the benefits of bisphosphonate therapy for osteoporosis treatment continue to outweigh the risks for most patients" [23]. That conclusion applies directly to Georgia patients weighing whether to fill their alendronate prescription.